-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L6fXQ0ZJeozJ7Enr7a5sss6VkcEzoffBpKsXxBEAyPTMAQ71H4FB8KdCr9QuI9zV 56vUE8Fmjfh5SxrDqV1dLw== 0001181431-07-066811.txt : 20071106 0001181431-07-066811.hdr.sgml : 20071106 20071106161939 ACCESSION NUMBER: 0001181431-07-066811 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071102 FILED AS OF DATE: 20071106 DATE AS OF CHANGE: 20071106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PANACOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001040017 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 113238476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-1551 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: V I TECHNOLOGIES INC DATE OF NAME CHANGE: 19980209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pelletier Robert CENTRAL INDEX KEY: 0001332700 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24241 FILM NUMBER: 071218218 BUSINESS ADDRESS: BUSINESS PHONE: 6172506034 MAIL ADDRESS: STREET 1: C/O EPIX PHARMACEUTICALS, INC. STREET 2: 161 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 rrd177109.xml R PELLETIER NOV 2 2007 FORM 4 X0202 4 2007-11-02 0 0001040017 PANACOS PHARMACEUTICALS, INC. PANC 0001332700 Pelletier Robert C/O PANACOS PHARMACEUTICALS, INC. 134 COOLIDGE AVENUE WATERTOWN MA 02048 0 1 0 0 Acting Princ. Acctg Officer Common Stock 2007-11-02 4 A 0 25000 0 A 29235 D 25,000 shares are restricted stock, which is currently unvested. Vesting will occur at the earlier of 1) an accomplishment by the Company of a specific milestone, 2) November 2, 2010, the third anniversary of the Grant Date, and 3) a change of control, as described in the applicable Restricted Stock Agreement. /s/ Robert Pelletier 2007-11-06 -----END PRIVACY-ENHANCED MESSAGE-----